Allergan Lawsuit Over Cyclosporine "Antibiotic" Classification Rejected
This article was originally published in The Pink Sheet Daily
Executive Summary
A drug may be classified as an "antibiotic," thereby exempting it from Waxman/Hatch exclusivity, even if its intended use is not fighting infectious disease, D.C. judge rules in Restasis case. Allergan says ruling will have "limited effect" because Restasis is patent-protected through 2014.